Menu
Your Cart

Short Fragment Enrichment

Short Fragment Enrichment
Apostle MiniEnrich for Enrichment of Short DNA fragments for NIPT and Oncology ApplicationsPrecise DNA sizing can boost sequencing efficiency, reduce cost, improve data quality, and even allow sequencing of low-input samples, while current pervasive DNA sizing approaches are incap- able of different..
$270.00
Apostle MiniEnrich for Enrichment of Short DNA fragments for NIPT and Oncology ApplicationsPrecise DNA sizing can boost sequencing efficiency, reduce cost, improve data quality, and even allow sequencing of low-input samples, while current pervasive DNA sizing approaches are incap- able of different..
$672.50
Showing 1 to 2 of 2 (1 Pages)
Nature Communications just published a clinical study, including 2125 cancer patients, 9 cancer types, using the Apostle Minimax cfDNA technology. This study demonstrates the ability of its model to detect early-stage cancers using cfDNA, including those of pancreatic origin, with high sensitivity that is comparable to that of late-stage detection. Congratulations to this clinical research team. To date, the Apostle Minimax cfDNA technology has been used in 2 articles published in Nature Medicine, 1 in Nature Communications, 1 in Science Translational Medicine, 1 in PNAS, and over 50 scientific articles in different journals.